NCT02218177View on ClinicalTrials.gov

Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Aflibercept

anti-VEGF treatment for wet age related macular degeneration

DRUG

Ranibizumab

anti-VEGF treatment for wet age related macular degeneration

PROCEDURE

Combination Photodynamic Therapy

Use of cold laser with an intravitreal injection of dexamethasone to treat wet age related macular degeneration

Trial Locations (1)

M2N4H3

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02218177 - Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD | Biotech Hunter | Biotech Hunter